Gallegos-Hernández JF, Abrego-Vázquez JA, Olvera-Casas A, Minauro-Muñoz GG, Ortiz-Maldonado AL

Language: Spanish
References: 17
Page: 141-145
PDF size: 252.49 Kb.

ABSTRACT

Introduction: Patients with bulky metastases of squamous cell carcinoma of the head and neck represent a challenge for the therapeutic decision; balance between oncological control and complications should be achieved. The therapeutic sequence has no impact on survival but sequelae. Objective: We analyze the oncological results in patients with bulky metastases on the neck treated with induction chemotherapy and with up-front neck dissection. Method: Retrospective analysis of patients undergoing treatment for cervical lymph node metastasis of squamous cell carcinoma; The therapeutic sequence was decided based on volume, resectability, site, and size of the primary and general condition of the patient. Overall survival was calculated based on human papilloma virus (HPV) status. Results: There were 30 patients, 22 men and eight women with a mean age of 57 years, 10 N3 and 20 N2. In 13 the HPV was positive, in 5 negative and in 12 the determination was not made. Seven patients were treated with initial chemotherapy, and 23 underwent neck dissection; the 5-year survival was 25%, and the prognosis was better in the positive HPV. Conclusion: The treatment of cervical metastasis depends on the possibility of resection. We should favor the initial surgery. The HPV is a factor of good prognosis.

REFERENCES

1. Gallegos-Hernández JF. El cáncer de cabeza y cuello. Factores de riesgo y prevención. Cir Cir. 2006;74:287-93.

2. Gallegos-Hernández JF. Cervical lymph node metastases of squamous cell carcinoma from unknown primary. Current diagnostic and therapeutic approach. An Orl Mex. 2016;61:57-65.

3. Elicin O, Albrecht T, Haynes AG, Bojaxhiu B, Nisa L, Caversaccio M, et al. Outcomes in advanced head and neck cancer treated with up-front neck dissection prior to (chemo)radiotherapy. Otolaryngol Head Neck Surg. 2016;154:300-8.

4. Sanabria A, Silver CE, Olsen KD, Medina JE, Hamoir M, Paleri V, et al. Is selective neck dissection indicated during salvage surgery for head and neck squamous cell carcinoma? Eur Arch Otolaryngol. 2014;271: 3111-9.

5. van der Putten L, de Bree R, Kuik DJ, Rietveld DH, Buter J, et al. Salvage laryngectomy: oncological and functional outcome. Oral Oncol. 2011;47:296-301.

6. Strojan P, Ferlito A, Langendijk JA, Corry J, Woolgar JA, Rinaldo A, et al. Cotemporary management of lymph node metastases from an unknown primary to the neck: a review of therapeutic options. Head Neck. 2013; 35:286-93.

7. Jouhi L, Halme E, Iriala H, Saarilahti K, Kouvunene P, Pukkila M, et al. Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland. Acta Oncol. 2018;57:541-51.

8. Flores-de la Torre C, Hernández-Hernández DM, Gallegos-Hernández JF. Human papilloma virus in patients with epidermoid head and neck carcinoma: a prognostic factor? Cir Cir. 2010;78:221-8.

9. Husain N, Neyaz A. Human papillomavirus associated head and neck squamous cell carcinoma: controversies and new concepts. J Oral Craniofac Res. 2017;7:198-205.

10. Wopken K, Bijl HP, Langendijk JA. Prognostic factors for tube feeding dependence after curative(chemo-)radiation in head and neck cancer: a systematic review of the literature. Radiother Oncol. 2017;21:32545-8.

11. Elicin O, Nisa L, Dal Pra A, Bojaxhiu B, Caversaccio M, Schmücking M, et al. Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: rationale, complications, toxicity rates and oncologic outcomes. A systematic review. Radiother Oncol. 2016;119:185-93.

12. Patil VM, Prabhash K, Noronha V, Joshi A, Dhumal S, Arya S, et al. Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers. Oral Oncol. 2014;50:1000-4.

13. Liu H, Li J, Zhou Y, Hu Q, Zeng Y, Mohammadreza MM. Human papillomavirus as a favorable prognostic factor in a subset of head and neck squamous cell carcinomas: a meta-analysis. J Med Virol. 2017;89:710-25.

14. Nevens D, Duprez F, Bonte K, Deron P, Huvenne W, Laenen A, et al. Upfront vs no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: tumor control and late toxicity. Radiother Oncol. 2017;124:220-4.

15. Tangthongkum M, Kirtsreesakul V, Supanimitjaroenporn P, Leelasawwatsuk P. Treatment outcome of advance staged oral cavity cancer: concurrent chemo-radiotherapy compared with primary surgery. Eur Arch Otorhinolaryngol. 2017;274:2567-72.

16. Huguet F, Schick U, Pointreau Y. Role of induction chemotherapy in head and neck cancer. Cancer Radiother. 2017;21:510-4.

17. Mehta V, Moore-Medlin T, Flores JM, Ma X, Ekshyyan O, Nathan CO. Survival outcomes based on systematic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer. Oncotarget. 2017;8:70907-15.